KFF poll links lack of trusted healthcare provider and social media use to belief in vaccine myths
By
Lauren Weber
Summary
A new KFF poll reveals that Americans who lack a trusted healthcare provider or frequently use social media and AI are more likely to believe vaccine myths. The poll highlights key demographic factors associated with vaccine misinformation susceptibility.
Source
bskyKFF poll links lack of trusted healthcare provider and social media use to belief in vaccine mythswashingtonpost.comKey quotes
· 1 pulledThose who lack a trusted health care provider or who often use social media or AI are more likely to believe vaccine myths, according to a poll released Tuesday by KFF, a health policy research and news organization.
You might also wanna read
Research Reveals People Endorse Misinformation as Symbolic Victory Rather Than Belief in Falsehoods
New research published in the Journal of Social Psychology reveals that some people endorse easily disproven misinformation because they vie
theconversation.com·8mo ago
CDC Modifies Position on Vaccines and Autism Under Kennedy's Leadership
The article discusses how the CDC, under the direction of Health and Human Services Secretary Robert F. Kennedy Jr., has modified its longst
newyorker.com·7mo agoRFK Jr.: HHS moves to restore public trust in vaccines
Tylenol-maker's stock declines amid RFK Jr's reported plans to suggest autism link
Shares of Tylenol-maker Kenvue dropped after reports that RFK Jr will suggest a link between acetaminophen use during pregnancy and autism.
bbc.com·9mo ago
RFK Jr Demands Retraction of Vaccine Study Finding No Aluminum-Disease Link
US health secretary and vaccine skeptic Robert F. Kennedy Jr has called for the retraction of a Danish study that found no link between alum
nature.com·10mo ago
Newborn Vitamin K Shot Refusals Linked to Rise in Preventable Infant Bleeding Deaths
This article investigates how a growing number of parents are refusing the vitamin K shot given to newborns at birth, leading to a resurgenc
ProPublica·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.